Please click here to log in with you RCPsych web account details; you will be redirected back to CPD Online.If you have forgotten your College web account details, you will be able to reset them here.
Please click here to log in if your institution has a subscription to CPD Online with Athens access.
Please click here to log in if you are subscribed through Medicom Netherlands.
If you having troubles signing in with the options above, please try this alternative login route.
About the author
Section 1: Treatment of
antidepressant-induced sexual dysfunction
(1.1) Section 1: Treatment of antidepressant-induced sexual
(1.2) Before you begin
(1.3) Clinical vignette: a woman who thought she was
(1.4) Comment: a woman who thought she was 'frigid'
(1.6) Suggested answers
(1.8) Suggested answers
(1.9) Overview of treatment strategies
(1.10) Modification of the current antidepressive treatment
(1.11) Treatment of sexual dysfunction targeting specific
(1.12) Other treatments
(1.14) Pharmacological reversal: target noradrenaline
(1.15) Interactive exercise: outlook: autoreceptors
(1.17) Pharmacological reversal: target serotonin
(1.19) Pharmacological reversal: target dopamine
(1.21) Pharmacological reversal: other targets
(1.22) Pharmacological reversal: target nitric oxide (NO)
(1.23) Phosphodiesterase5 (PD5)-inhibitors
head to head
(1.25) It all starts with nitric oxide…
(1.26) PD5-inhibitors: contraindications and warnings
- what your patient should know
(1.27) Yet another story...
(1.29) Female sexual dysfunctions: licensed pharmacological
(1.30) Female sexual dysfuction: drugs that remain
(1.31) Section 1: Recap
(1.32) Section 1:
Section 2: Other treatments for
(2.1) Section 2: Other treatments for sexual dysfunction
(2.3) Suggested answers
(2.4) Hormone treatments for women
(2.5) Why has HRT fallen out of favour with women?
(2.6) HRT: what does it mean for the individual patient?
(2.7) Hormone treatments for women - potential adverse
(2.9) Suggested answers
(2.10) Hormone treatments for men
(2.13) Suggested answers
(2.14) Complementary medicines for sexual dysfunction
(2.15) Recommending complementary medicines: issues
(2.16) Hypomanic episodes
(2.18) Section 2: Recap
(2.19) Section 2:
Section 3: Formal aspects of
prescribing for sexual dysfunction
(3.1) Section 3: Formal aspects of prescribing for sexual
(3.2) Prescribing unlicensed medications: recommendations
(3.3) The GMC requirements for prescribing unlicensed
(3.4) Informed consent
(3.5) The criteria for informed consent: quick recap
(3.6) Reimbursement for treatments
(3.7) The BNF requirements for prescribing for erectile
(3.8) The severe distress clause
(3.9) Section 3: Recap
(3.10) Section 3: